Wall Street brokerages expect Cara Therapeutics Inc (NASDAQ:CARA) to announce sales of $5.14 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Cara Therapeutics’ earnings, with the highest sales estimate coming in at $5.30 million and the lowest estimate coming in at $5.00 million. Cara Therapeutics reported sales of […]
